Search
Barmastine
go.drugbank.com/drugs/DB21253ExperimentalBarmastine is a small molecule drug. The usage of the INN stem '-astine' in the name indicates that Barmastine is a antihistaminic. Barmastine has a monoisotopic molecular weight of 483.24 Da.
Zanoterone
go.drugbank.com/drugs/DB21384ExperimentalZanoterone is a small molecule drug. The usage of the INN stem '-terone' in the name indicates that Zanoterone is a antiandrogen. Zanoterone has a monoisotopic molecular weight of 416.21 Da.
Isoprenaline
go.drugbank.com/drugs/DB01064ApprovedInvestigational[A233724,A233729] The US patent from 1943 states that this compound had a wider therapeutic index and a stronger action than [adrenaline]. … Isoprenaline is a non-selective beta adrenergic receptor agonist indicated to treat heart block, Adams-Stokes attacks, bronchospasm in anesthesia, cadiac arrest, hypovolemic shocks, septic shock, hypoperfusion
Categories: Compounds used in a research, industrial, or household settingInternational brands: Proternol LAncitabine
go.drugbank.com/drugs/DB20595ExperimentalAncitabine has a monoisotopic molecular weight of 225.07 Da. … Ancitabine is a small molecule drug.
Nelistotug
go.drugbank.com/drugs/DB19334InvestigationalNelistotug is under investigation in clinical trial NCT06062420 (A Platform Study of Novel Immunotherapy Combinations as First-line Treatment in Participants With PD-L1 Positive Recurrent/metastatic Squamous
Galocitabine
go.drugbank.com/drugs/DB21373ExperimentalGalocitabine has a monoisotopic molecular weight of 439.14 Da. … Galocitabine is a small molecule drug.
Alpibectir
go.drugbank.com/drugs/DB21561InvestigationalAlpibectir has a monoisotopic molecular weight of 332.1 Da. … Alpibectir is a small molecule drug.
Ceperognastat
go.drugbank.com/drugs/DB21591InvestigationalCeperognastat has a monoisotopic molecular weight of 383.14 Da. … Ceperognastat is a small molecule drug.
Ranosidenib
go.drugbank.com/drugs/DB21727InvestigationalRanosidenib has a monoisotopic molecular weight of 453.12 Da. … Ranosidenib is a small molecule drug. Ranosidenib is under investigation in clinical trial NCT06387069 (A Study to Evaluate HMPL-306 in Patients With IDH1- and IDH2-mutated Acute Myeloid Leukemia).
Rosuvastatin
go.drugbank.com/drugs/DB01098ApprovedInvestigationalevents (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks. … of death in high-income countries and a major cause of morbidity around the world.
Products: ROSU 1A PHARMA 5MG, ROSU 1A PHARMA 10MG